176 related articles for article (PubMed ID: 37308689)
1. Pirin is a prognostic marker of human melanoma that dampens the proliferation of malignant cells by downregulating JARID1B/KDM5B expression.
Penas C; Arroyo-Berdugo Y; Apraiz A; Rasero J; Muñoa-Hoyos I; Andollo N; Cancho-Galán G; Izu R; Gardeazabal J; Ezkurra PA; Subiran N; Alvarez-Dominguez C; Alonso S; Bosserhoff AK; Asumendi A; Boyano MD
Sci Rep; 2023 Jun; 13(1):9561. PubMed ID: 37308689
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of RBP2-H1 variant of JARID1B in melanoma.
Kuźbicki Ł; Lange D; Stanek-Widera A; Chwirot BW
BMC Cancer; 2017 Dec; 17(1):854. PubMed ID: 29246117
[TBL] [Abstract][Full Text] [Related]
3. JARID1B expression in human melanoma and benign melanocytic skin lesions.
Kuźbicki L; Lange D; Strączyńska-Niemiec A; Chwirot BW
Melanoma Res; 2013 Feb; 23(1):8-12. PubMed ID: 23262439
[TBL] [Abstract][Full Text] [Related]
4. RBP2-H1/JARID1B is a transcriptional regulator with a tumor suppressive potential in melanoma cells.
Roesch A; Mueller AM; Stempfl T; Moehle C; Landthaler M; Vogt T
Int J Cancer; 2008 Mar; 122(5):1047-57. PubMed ID: 17973255
[TBL] [Abstract][Full Text] [Related]
5. Pirin inhibits cellular senescence in melanocytic cells.
Licciulli S; Luise C; Scafetta G; Capra M; Giardina G; Nuciforo P; Bosari S; Viale G; Mazzarol G; Tonelli C; Lanfrancone L; Alcalay M
Am J Pathol; 2011 May; 178(5):2397-406. PubMed ID: 21514450
[TBL] [Abstract][Full Text] [Related]
6. Histone demethylase JARID1B/KDM5B promotes aggressiveness of non-small cell lung cancer and serves as a good prognostic predictor.
Kuo KT; Huang WC; Bamodu OA; Lee WH; Wang CH; Hsiao M; Wang LS; Yeh CT
Clin Epigenetics; 2018 Aug; 10(1):107. PubMed ID: 30092824
[TBL] [Abstract][Full Text] [Related]
7. Altered Splicing of JARID1B in Development of Human Cutaneous Melanoma?
Kuźbicki Ł; Lange D; Strączyńska-Niemiec A; Chwirot BW
Appl Immunohistochem Mol Morphol; 2016 Mar; 24(3):188-92. PubMed ID: 25789538
[TBL] [Abstract][Full Text] [Related]
8. JARID1B promotes colorectal cancer proliferation and Wnt/β-catenin signaling via decreasing CDX2 level.
Huang D; Xiao F; Hao H; Hua F; Luo Z; Huang Z; Li Q; Chen S; Cheng X; Zhang X; Fang W; Hu X; Liu F
Cell Commun Signal; 2020 Oct; 18(1):169. PubMed ID: 33109187
[TBL] [Abstract][Full Text] [Related]
9. JARID1B protein expression and prognostic implications in uveal melanoma.
Radberger P; Radberger A; Bykov VJ; Seregard S; Economou MA
Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4442-9. PubMed ID: 22669717
[TBL] [Abstract][Full Text] [Related]
10. Histone Demethylase JARID1B Is Overexpressed in Osteosarcoma and Upregulates Cyclin D1 Expression via Demethylation of H3K27me3.
Wang W; Zheng K; Pei Y; Zhang X
Oncol Res; 2018 Apr; 26(3):373-384. PubMed ID: 28492139
[TBL] [Abstract][Full Text] [Related]
11. Pirin delocalization in melanoma progression identified by high content immuno-detection based approaches.
Licciulli S; Luise C; Zanardi A; Giorgetti L; Viale G; Lanfrancone L; Carbone R; Alcalay M
BMC Cell Biol; 2010 Jan; 11():5. PubMed ID: 20089166
[TBL] [Abstract][Full Text] [Related]
12. A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth.
Roesch A; Fukunaga-Kalabis M; Schmidt EC; Zabierowski SE; Brafford PA; Vultur A; Basu D; Gimotty P; Vogt T; Herlyn M
Cell; 2010 May; 141(4):583-94. PubMed ID: 20478252
[TBL] [Abstract][Full Text] [Related]
13. Histone demethylase JARID1B/KDM5B is a corepressor of TIEG1/KLF10.
Kim J; Shin S; Subramaniam M; Bruinsma E; Kim TD; Hawse JR; Spelsberg TC; Janknecht R
Biochem Biophys Res Commun; 2010 Oct; 401(3):412-6. PubMed ID: 20863814
[TBL] [Abstract][Full Text] [Related]
14. Identification of small molecule inhibitors of Jumonji AT-rich interactive domain 1B (JARID1B) histone demethylase by a sensitive high throughput screen.
Sayegh J; Cao J; Zou MR; Morales A; Blair LP; Norcia M; Hoyer D; Tackett AJ; Merkel JS; Yan Q
J Biol Chem; 2013 Mar; 288(13):9408-17. PubMed ID: 23408432
[TBL] [Abstract][Full Text] [Related]
15. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
[TBL] [Abstract][Full Text] [Related]
16. Jumonji AT-rich interactive domain 1B overexpression is associated with the development and progression of glioma.
Fang L; Zhao J; Wang D; Zhu L; Wang J; Jiang K
Int J Mol Med; 2016 Jul; 38(1):172-82. PubMed ID: 27246838
[TBL] [Abstract][Full Text] [Related]
17. Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinoma.
Lin CS; Lin YC; Adebayo BO; Wu A; Chen JH; Peng YJ; Cheng MF; Lee WH; Hsiao M; Chao TY; Yeh CT
Cancer Lett; 2015 Nov; 368(1):36-45. PubMed ID: 26184998
[TBL] [Abstract][Full Text] [Related]
18. Histone demethylase JARID1B promotes cell proliferation but is downregulated by N-Myc oncoprotein.
Zhang L; Sokolowski N; Atmadibrata B; Liu T
Oncol Rep; 2014 Apr; 31(4):1935-9. PubMed ID: 24481781
[TBL] [Abstract][Full Text] [Related]
19. JARID1B modulates lung cancer cell proliferation and invasion by regulating p53 expression.
Shen X; Zhuang Z; Zhang Y; Chen Z; Shen L; Pu W; Chen L; Xu Z
Tumour Biol; 2015 Sep; 36(9):7133-42. PubMed ID: 25877751
[TBL] [Abstract][Full Text] [Related]
20. JARID1B deletion induced apoptosis in Jeko-1 and HL-60 cell lines.
Su H; Ma X; Huang Y; Han H; Zou Y; Huang W
Int J Clin Exp Pathol; 2015; 8(1):171-83. PubMed ID: 25755704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]